Brief: Anika Therapeutics Q1 revenue USD 37.924 million
09/05/2023 21:09
May 9 (Reuters) - Anika Therapeutics Q1 revenue USD 37.924 million. * Q1 income from operations USD -12.553 million * Q1 pretax profit USD -12.014 million * Q1 gross profit USD 22.843 million * Q1 net income USD -10.35 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%